No Data
No Data
Humanwell Healthcare Semi-Annual Report for 2024
Humanwell Healthcare 2024 Half-Year Report Summary.
Humanwell Healthcare (600079.SH): Acquires subsidiary's equity.
On July 26, Gelonhui reported that Humanwell Healthcare (600079. SH) announced that in March 2022, the company acquired a 40% equity interest in Hubei Gedian Humanwell Pharmaceutical Auxiliary Co., Ltd. (referred to as "Gedian Pharmacy Auxiliary") from Wuhan Yaoxing Pharmaceutical Co., Ltd. (referred to as "Yaoxing Pharmaceutical") for a transfer payment of 100 million yuan. After the completion of the transaction, the company and its controlling subsidiary Hubei Gedian Humanwell Pharmaceuticals Co., Ltd. (referred to as "Gedian Humanwell", in which the company holds an 81.07% equity interest) will collectively hold 80% equity interest in Gedian Pharmacy Auxiliary. Recently, the controlling shareholder, Wuhan Contemporary Technological Industry Group Co., Ltd.
Humanwell Healthcare's Unit Gets Nod to Trial Two Drugs
Humanwell Healthcare (600079.SH): Clinical trial approval notice received for citric acid sufentanil injection.
On July 25th, Gelunhui announced that Humanwell Healthcare (600079.SH) announced that its holding subsidiary, Yichang Humanwell Pharmaceutical Co., Ltd. (referred to as "Yichang Humanwell", with the company holding 80% of its equity), recently received the "Drug clinical trial approval notice" signed and issued by the National Medical Products Administration for Glycine fentanyl injection. Fentanyl is a potent opioid analgesic and a specific μ-opioid receptor agonist.
Smart A-share restriction lifting list | July 15th
On July 15, a total of 33 listed companies had their restricted stocks lifted, with a total market value of approximately 8.026 billion yuan. The specific situation of restricted stock lifting today is as follows: Stock Code, Restricted Stock Type, Number of Unlocked Shares of Chenming Paper (000488), Stock-based Incentive Restricted Shares, 22.193 million shares; Humanwell Healthcare (600079), Stock-based Incentive Restricted Shares, 58.35 trillion shares; Jingdian Optoelectronics (600537), Stock-based Incentive Restricted Shares, 4.125 million shares; Midea Group Co., Ltd (000333), Stock-based Incentive Restricted Shares, 10.4388 million shares; Talkweb Information System (002261), Stock-based Incentive Restricted Shares, 2.343 million shares; Dahua.
No Data